Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.

  • Revenue in EUR (TTM)14.27bn
  • Net income in EUR94.00m
  • Incorporated2006
  • Employees31.30k
  • Location
    Evonik Industries AGRellinghauser Strasse 111ESSEN 45128GermanyDEU
  • Phone+49 20117701
  • Fax+49 2 011773475
  • Websitehttps://corporate.evonik.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AlzChem Group AG563.86m61.84m1.50bn1.73k24.176.3716.932.666.106.1055.6023.131.051.677.52326,877.7011.598.3814.6810.7766.5559.1311.006.841.7727.400.163535.592.518.0656.1924.640.817319.14
Lanxess AG5.89bn-243.00m1.72bn11.80k--0.44184.500.2929-2.81-2.8168.1945.200.66793.459.82477,224.80-2.750.3874-3.250.478520.5222.72-4.110.57531.29-0.41720.3881210.40-5.18-1.3278.98---8.83-36.25
K+S AG3.64bn-1.70bn2.51bn11.36k--0.5894--0.6903-9.49-9.4920.3223.800.44334.575.44317,413.70-20.704.08-22.484.8211.9221.93-46.7010.052.33--0.103919.65-5.677.46-131.82--0.632430.26
Wacker Chemie AG5.57bn21.70m4.01bn16.62k174.140.89477.250.72050.44160.4416112.1785.950.63612.866.74334,573.500.43087.020.51758.7015.2821.690.67739.281.642.840.304648.76-10.633.03-23.15--9.4437.97
Evonik Industries AG14.27bn94.00m6.83bn31.30k73.870.81835.510.47890.19850.200630.8517.920.74874.248.68446,789.800.5721.530.71611.8622.5625.060.7642.120.79786.760.3481176.60-0.72052.95147.74-21.67-0.92610.3454
Brenntag SE15.65bn417.90m8.12bn18.10k19.441.888.820.51892.892.89108.3129.901.438.016.88863,547.103.866.185.338.8125.1423.662.703.941.295.900.426340.41-3.444.84-25.002.8210.9010.93
Symrise AG4.99bn506.93m10.32bn12.98k20.322.7812.692.073.633.6335.7326.570.63772.394.88392,117.306.535.148.006.0940.5737.9310.248.380.827413.000.392741.535.677.9640.4610.146.854.78
Data as of Feb 06 2026. Currency figures normalised to Evonik Industries AG's reporting currency: Euro EUR

Institutional shareholders

11.76%Per cent of shares held by top holders
HolderShares% Held
BlackRock Investment Management LLCas of 29 Jan 20269.91m2.13%
The Vanguard Group, Inc.as of 07 Jan 20269.61m2.06%
BlackRock Fund Advisorsas of 09 Jan 20265.58m1.20%
Norges Bank Investment Managementas of 30 Jun 20255.00m1.07%
Dimensional Fund Advisors LPas of 08 Jan 20264.98m1.07%
Magallanes Value Investors SA SGIICas of 30 Jun 20254.75m1.02%
BlackRock Asset Management Deutschland AGas of 09 Jan 20264.11m0.88%
BlackRock Advisors (UK) Ltd.as of 09 Jan 20263.86m0.83%
Wellington Management Co. LLPas of 09 Jan 20263.62m0.78%
Geode Capital Management LLCas of 29 Jan 20263.36m0.72%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.